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In the adult the interface between the cerebrospinal fluid and the brain is lined by
the ependymal cells, which are joined by gap junctions. These intercellular connections
do not provide a diffusional restrain between the two compartments. However, during
development this interface, initially consisting of neuroepithelial cells and later radial glial
cells, is characterized by “strap” junctions, which limit the exchange of different sized
molecules between cerebrospinal fluid and the brain parenchyma. Here we provide a
systematic study of permeability properties of this inner cerebrospinal fluid-brain barrier
during mouse development from embryonic day, E17 until adult. Results show that at fetal
stages exchange across this barrier is restricted to the smallest molecules (286Da) and the
diffusional restraint is progressively removed as the brain develops. By postnatal day P20,
molecules the size of plasma proteins (70 kDa) diffuse freely. Transcriptomic analysis of
junctional proteins present in the cerebrospinal fluid-brain interface showed expression of
adherens junctional proteins, actins, cadherins and catenins changing in a development
manner consistent with the observed changes in the permeability studies. Gap junction
proteins were only identified in the adult as was claudin-11. Immunohistochemistry was
used to localize at the cellular level some of the adherens junctional proteins of genes
identified from transcriptomic analysis. N-cadherin, β- and α-catenin immunoreactivity was
detected outlining the inner CSF-brain interface from E16; most of these markers were
not present in the adult ependyma. Claudin-5 was present in the apical-most part of radial
glial cells and in endothelial cells in embryos, but only in endothelial cells including plexus
endothelial cells in adults. Claudin-11 was only immunopositive in the adult, consistent
with results obtained from transcriptomic analysis. These results provide information
about physiological, molecular and morphological-related permeability changes occurring
at the inner cerebrospinal fluid-brain barrier during brain development.
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INTRODUCTION
The exchange of molecules between the brain and the periph-
ery is restricted by specific cellular and biochemical mechanisms
present at several interfaces between these two compartments: the
blood–brain barrier proper, the blood–cerebrospinal fluid (CSF)
barrier, the blood-arachnoid barrier and the (inner) CSF–brain
barrier only present during brain development (Møllgård et al.,
1987; Saunders et al., 2012). The morphological basis of blood–
brain and blood–CSF barriers is the presence of tight junctions
between cerebral vascular endothelial cells and choroid plexus
epithelial cells respectively. These junctions restrict free diffu-
sion between the blood, the brain parenchyma and the CSF (for
Abbreviations: CSF, cerebrospinal fluid; RNA-Seq, RNA sequencing; BDA,
biotinylated dextran amine; BED; biotin ethylenediamine; kDa, kilodalton.
reviews see Saunders et al., 1999, 2000, 2012; Dziegielewska and
Saunders, 2002; Ek et al., 2012; Engelhardt and Liebner, 2014).
Much less is known about the development of CSF–brain inter-
face. Junctions between cells lining the ventricular system of the
developing brain were first described on the basis of conventional
electron microscopy as modified tight or intermediate junctions,
or as desmosomes (Tennyson and Pappas, 1962; Duckett, 1968;
Levitt et al., 1981). Subsequent studies characterized these junc-
tions in fetal sheep using thin-section and freeze-fracture electron
microscopy and established that they had a very different struc-
tural arrangement compared with tight junctions. Unlike tight
junctions, which appear to join cells in a “belt-like fashion”
at their luminal lateral cell membranes, these novel junctions,
named “strap junctions,” appeared to encircle cells from their
ventricular surface (Møllgård et al., 1987) and were shown to
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hinder the free diffusion of solutes from the CSF into the fetal
brain (Fossan et al., 1985). In contrast to tight junctions of blood–
brain and blood–CSF barriers, which are present from the earliest
stages of brain development and remain throughout adulthood
(Møllgård and Saunders, 1986; Mishra and Teale, 2012; Saunders
et al., 2012), strap junctions are only present during development,
with minimal gap junctions between some neuroepithelial cells;
in the mature brain only gap junctions are present (Brightman
and Reese, 1969; Møllgård and Saunders, 1986; Møllgård et al.,
1987; Iliff et al., 2012). Additional evidence for the presence of a
developmentally regulated CSF–brain barrier came from a study
examining the cellular distribution of native and foreign albu-
mins injected into fetal and neonatal lateral ventricles of rats
(Cavanagh andWarren, 1985). This study showed that both types
of albumin were distributed in some (but not all) cells lining the
ventricles suggesting specialized uptake rather than paracellular
unrestricted diffusion (Cavanagh and Warren, 1985).
The fetal-specific interface that separates CSF from the brain’s
internal milieu is thought to control the transfer and diffusion
of solutes into the brain and play an important role in restrict-
ing access of protein, present in high concentration in fetal CSF
(Dziegielewska et al., 1980, 1981, 1986, 1989; Adinolfi, 1985;
Dziegielewska and Saunders, 1988), across the ventricular zone,
which initially consists of neuroepithelial cells that subsequently
differentiate to radial glial cells prior to neurogenesis. This, com-
bined with an increase in colloidal osmotic pressure due to
the high protein concentration responsible for the expansion of
the ventricles and outward growth of the brain (Desmond and
Jacobson, 1977), are fundamental mechanisms controlling nor-
mal brain development (Saunders, 1992; Johansson et al., 2008;
Saunders et al., 2012). The presence of this diffusion restraint
during brain development has been suggested to be important
for normal cortical development (Stolp et al., 2011b) and its dis-
turbance is thought to contribute to several neurodevelopmental
pathologies such as autism (Stolp, 2013; Stolp et al., 2013).
The present study is the first comprehensive investigation into
the permeability properties of the inner CSF-brain interface dur-
ing development, using lipid insoluble molecular markers with a
range of sizes from 286 to 70,000Da. We report that permeabil-
ity of this barrier in mouse brain gradually changes from highly
restrictive at fetal ages to an unrestricted diffusion in the adult.
Molecular characterization, using RNA sequencing performed at
a fetal and adult age, identified several known junctional proteins
that are expressed at the CSF-brain barrier in a developmentally
regulated manner. In addition to the transcriptomic analysis we
also demonstrated that the change in the permeability character-
istics coincided with changes in the cellular distribution of several
junctional proteins such as cadherins, catenins and claudin-5.
We propose that these junctional proteins are involved in the
formation of strap junctions and in regulation of the changing
diffusional properties of this barrier.
MATERIALS AND METHODS
ANIMAL EXPERIMENTATION
Ethics statement
All experimental protocols were approved by the Animal
Ethics Committee, University of Melbourne (Application ID
1112115.2).
Animal experiments
Time-mated pregnant Swiss Pro mice were obtained from the
Animal Resource Centre Pty. Ltd. (ARC, Perth, Australia).
Animals were housed in the Biomedical Sciences Animal Facility
(University of Melbourne) in sterile micro-isolator cages at 20◦C
on a 12 h light/dark cycle with food and water ad libitum.
Ages of mice used for permeability studies and for estimates
of total protein concentration in plasma and CSF were: embry-
onic day (E) 17, E19 and postnatal day (P) 0, P10, P20 and
adult (20–25 g). For transcriptome analysis, RNA-Seq, ventricu-
lar/ependymal layer was dissected out from fetal brains at E17/18,
and adult (see below). For morphological studies paraffin embed-
ded sections from fetal stages, E15/16, E17-19 and postnatal
stages, P15, P20 and adult mice brains were used. These were
obtained from previous studies (Liddelow et al., 2012).
Anesthesia
In experiments involving fetal animals, pregnant mice (E17–E19)
were anesthetized by an intraperitoneal (i.p.) injection of ure-
thane (30% in distilled water, Veterinary Companies of Australia
(VCA), Australia). Two doses of 0.2ml were given 20min apart.
Animals were monitored during this process and pain reflexes
were observed. When the pain reflexes were no longer evident,
mice were placed supine on a heated pad (33◦C) and the uterine
horns were exposed. Each fetus was removed consecutively from
the uterine horn. After all fetuses were removed, the mother was
killed by transection of the heart.
Postnatal pups of both sexes (P0, P10, and P20) and
adult female mice were individually anesthetized using inhaled
Isoflurane (VCA). Once deep anesthesia was obtained the ani-
mals were placed under the dissecting microscope, and several
experimental procedures were conducted as described below.
Total protein concentration
Blood and CSF were collected from 3 to 4 pups at each age and
from 3 to 4 adults. Blood was collected from the heart of termi-
nally anesthetized animals using either a heparinized 1ml syringe
with a 26-gauge needle (adults) or a heparinized pulled glass
micro-capillary (fetuses and postnatal pups) and centrifuged to
separate plasma. CSF was collected from the cisterna magna via
gentle suction using a fine glass micro-capillary and PVC tubing
to obtain paired samples. CSF samples were inspected under a
microscope for blood contamination (Habgood et al., 1993). For
fetal animals CSF samples were pooled from several littermates
to obtain a large enough volume. Plasma and CSF samples were
stored at −20◦C until use.
Total protein concentrations in plasma and CSF samples
were estimated using the Bradford method (Bradford, 1976) and
Protein Standard (Binding Sites, UK). All dilutions of the stan-
dards in the range of 1–10 ug/100 ul (in triplicate) and samples
(in duplicate) were made in sterile saline. Plasma samples were
diluted 1000x while CSF ranged from 100x to 10x depending
on the age (Dziegielewska et al., 1979). The volume of both
the standards and the samples was always 100μl as described
in the original method (Bradford, 1976). The concentration of
the total protein in each sample was measured from constructed
concentration curves and expressed inmg 100ml−1 a standard
unit in the field (Dziegielewska et al., 1979, 1989).
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CSF-brain barrier permeability experiments
Rhodamine–conjugated biotinylated dextran amines, BDAs, of
molecular masses 3000 Da (3 kDa), 10000 Da (10 kDa) and
70000Da (70 kDa) and a 286Da biotin ethylenediamine hydro-
bromide (BED) obtained from Molecular Probes (USA) were
used in these experiments. Three to four individual mice from
at least two separate litters were obtained for each experiment.
All probes were diluted in sterile saline (25mgml−1) and were
injected into the right ventricle of anesthetized animals via a glass
microcapillary and gentle pressure (see Figure 1). Injected vol-
umes are listed in Table 1. Following injection the markers were
allowed to distribute for a further 2–3min (fetal), 5min (postna-
tal ages to P20) or 10min (adults) so that each dextran would flow
into the contralateral ventricle. Brains of animals injected with
fluorescence BDAs were dissected out from the skull and fixed by
immersion in 4% paraformaldehyde (PFA) for 24 h at 4◦C. Brains
from pups injected with BED were fixed in Bouin’s fixative for
24 h and processed for paraffin embedding (see below).
Fluorescence microscopy
At the end of permeability experiments and following fixation,
brains were embedded in high gel strength 4% Agar (Sigma
Aldrich) and sectioned in the coronal plane at 80μm using a
vibrating microtome (Leica). All sections containing the lateral
FIGURE 1 | Injection of biotin dextran amines into the ventricular
system of mice. Schematic diagrams (A,B) and images (C,D) illustrating
the methods used to inject dextrans into the lateral ventricles of mouse
brain. (A) Micropipette injection of dextran into lateral ventricle. (B)
Illustrates surface landmarks for injection site. (C) Distribution of dextran
following injection. (D) Method used to measure diffusion distance of
dextrans (red) using ImageJ64. Mean of 10 measurements, spanning the
ventricular zone at right angles to ventricular surface (arrows). Scale bars
500μm in (C,D). L, length; W, width.
Table 1 | Volumes and times of injected probes at different ages.
Age Volume Time
E17, P0 1μl 2, 3min
P5, P10 5μl 5min
P20, Adult 10μl 5, 10min
ventricles were collected for analysis. Each section was mounted
on a glass slide using fluorescence mounting medium (DAKO).
Slides were kept at 4◦C and covered with foil to restrict light expo-
sure. All sections were viewed with an Olympus BX50 fluorescent
light microscope with a filter specific for rhodamine. Digitized
photographs were taken using an Olympus DP70 camera that was
attached to the microscope and processed in Adobe Photoshop
CC® (Adobe® Systems Incorporated, USA). The brightness and
color balance functions were used to obtain images with a back-
ground close to black to enhance contrast and to standardize
obtained images.
Immunohistochemistry
Paraffin-embedded coronal sections from mice from fetal ages
E15-16, E17-19 and postnatal ages P15, P20 and adult were
obtained from previous studies (Liddelow et al., 2012). Prior
to immunohistochemical processing sections were deparaffinized
and rehydrated in xylene followed by a series of graded alco-
hols, treated with a 0.5% solution of hydrogen peroxide in
methanol for 15min to quench endogenous peroxidase, and then
rinsed in TRIS buffered saline (TBS, 5mM Tris-HCl, 146mM
NaCl, pH 7.6). Non-specific binding was removed by incuba-
tion for 30min with blocking buffer (ChemMate antibody diluent
S2022, DakoCytomation, Glostrup, Denmark) at room tempera-
ture. The sections were incubated overnight at 4◦C with rabbit
polyclonal or mouse monoclonal antibodies against claudin-
5, claudin-11, α-catenin, β-catenin and N-cadherin (details in
Table 2). Following primary antibody incubation the sections
were washed with TBS and incubated for 30min with the REAL
EnVision™ Detection System, Peroxidase/DAB+, Rabbit/Mouse,
(K5007) from DakoCytomation. The sections were counter-
stained with Mayer’s hematoxylin and dehydrated in graded
alcohols followed by xylene and coverslipped with DPX mount-
ing medium. Control sections were incubated with mouse IgG1,
IgG2a or non-specific unrelated rabbit antibodies, as well as sub-
jected to omission of primary or secondary antibodies. These
were always blank.
Sections were viewed with an Olympus bright field micro-
scope and photographs taken with only brightness manipulated
to obtain comparable images. Three to four sections from a min-
imum of three brains at each age were developed with each
antibody.
Detection of BED
Brains from BED injected fetal mice were paraffin-embedded
as described previously (Liddelow et al., 2011) and 5μm
serial coronal sections cut through the cortex encompassing
Table 2 | Antibodies used for immunohistochemistry.
Antigen Manufacturer Code no. Species Dilution
Cadherin N Abcam ab12221 Rabbit 1:500
Catenin a E Santa cruz sc-7894 Rabbit 1:100
Catenin ß Zymed 13-8400 Mouse 1:100
Claudin 5 Abcam ab15108 Rabbit 1:150
Claudin 11 Abcam ab53041 Rabbit 1:1500
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the lateral ventricles. Five sections spanning the whole lat-
eral ventricular system were processed for histological stain-
ing using the ABC detection method (Vector laboratories)
and 3, 3′–diaminobenzidine (DAB) chromagen substrate devel-
oper (DAKO) following manufactures’ instructions. De-waxing,
rehydration, dehydration and mounting of sections with DPX
were performed as described above. Sections from brains not
injected with BED served as controls and these were always
blank.
RNA sequencing analysis
The lateral aspect of the ventricular zone of E17/18 and adult
mouse brains was carefully dissected (Figure 1). Tissue from five
brains, collected from three different litters, was pooled randomly
to obtain three equal samples at each age and was processed for
RNA sequencing.
RNA extraction
Total RNA was extracted from pools of E17/18 lateral ventric-
ular zone and adult lateral ependymal zone (n = 3 for both
ages) using the RNeasy Mini Kit, Qiashredder columns and
gDNA removal columns (Qiagen, Valencia, CA, USA) according
to standard supplier protocol. Total RNA samples were quan-
tified using a NanoDrop ND-1000 UV-VIS spectrophotometer
(Thermo Scientific, Wilmington, DE, USA).
Illumina next generation RNA sequencing
As previously described for an RNA-Seq study of developing
choroid plexus (Liddelow et al., 2013) sequencing was performed
at the Australian Genome Research Facility (Melbourne, VIC,
Australia). A cDNA library was prepared from 10μg of total
RNA using the mRNA-Seq Sample Preparation Kit (Illumina, San
Diego, CA, USA) according to standard manufacturer protocol.
Quality of the library was verified using a DNA 1000 chip using
the Agilent 2100 Bioanalyzer (Agilent) and quantified by fluo-
rimetry. Only samples with an RNA Integrity Number close to
10.0 were kept for further sequencing experiments. The library
was subjected to 100 bp single end read cycles of sequencing on
an Illumina HiSeq 2000 sequencer as per manufacturer protocol.
Cluster generation was performed on a c-Bot (Illumina) with a
single read cluster generation kit.
RNA sequencing data analysis
Short reads were trimmed to remove ambiguous bases from
the start and segments with low quality scores from the end,
as indicated by the ascii character “B” in Illumina 1.5 phred
score encoding. Trimmed reads were mapped with Bowtie version
0.12.7 (Langmead et al., 2009) to the Ensembl (Hubbard et al.,
2009) rat genome, release 61. Reads that did not map uniquely
were discarded. The number of reads mapped to nuclear genes
was determined with HTSeq (Anders et al., 2015) version 0.4.7p4,
using the default “union” counting option. Differential expression
between the adult and embryonic samples was detected using an
exact test in the Bioconductor (Gentleman et al., 2004) edgeR
package, version 2.4.0 (Robinson et al., 2010), with common
dispersion used to estimate variance between samples. Genes con-
sidered significantly differentially expressed were those with a
p-value of less than 0.05 after Benjamini-Hochberg false discovery
rate correction. A combination of gene ontology annotation and
manual curation was used to select genes encoding proteins that
form part of a cell junction. Gene ontology descriptions for rat
were downloaded from Biomart (Hubbard et al., 2009), and genes
with “junction” mentioned in their gene ontology description
were selected. Junction genes of interest were then extracted from
this list. Similar searches were carried for other functional cat-
egories as described in the Results/Discussion below. For initial
analysis genes with >100 sequence reads and age-related fold
changes (FC)>2.0 (log2FC> 1.0) were collated and are summa-
rized in Tables 1–4. For more specific analysis of some particular
function categories a lower cut-off of 10 sequence reads was
used. Complete sequencing data have been deposited in the Gene
Table 3 | RNASeq expression of junction-associated genes in
embryonic day 17 (E17) and adult ependymal cells.
(A) E17 expression (B) Adult expression
Gene ID FPKM (AVE) Gene ID FPKM (AVE)
Actb 805.8 Cldn11 304.7
Ctnnb1 114.6 Actb 115.8
Actr1a 39.1 Gja1 35.8
Cdh2 23.4 Pkp4 31.2
Actr2 14.2 Ctnnb1 29.0
Actl6b 7.7 Actr1a 10.3
Ctnna2 4.6 Actr1b 6.8
Actr3 4.3 Actr2 6.0
Pcdhgc3 3.8 Gjc3 5.5
Ctnnd2 3.8 Jam3 3.5
Actr10 2.7 Ctnna1 2.6
Actr1b 2.1 Actn4 2.2
Actg1 2.0 Ctnnd2 2.0
Ctnnbip1 1.6 Cdh2 1.9
Ctnna1 1.4 Gjb1 1.9
Actn4 1.3 Ctnna2 1.3
Ctnnbl1 1.3 Actr10 1.2
Cdh13 1.2 Actr3b 1.1
Cldn5 1.0 Pcdhgc3 1.1
Cdh11 0.8 Actr3b 1.1
Cdh4 0.7 Actl6b 0.9
Actr3b 0.7 Pcdh10 0.8
Pkp4 0.6 Tjp1 0.7
Pcdh10 0.5 Cdh13 0.5
Gja1 0.3 Jam2 0.4
Pcdh17 0.3 Cldn5 0.3
Tjp1 0.2 Ctnnbip1 0.3
Jam2 0.2 Cdh11 0.2
Jam3 0.2 Ctnnbl1 0.2
Cldn11 0.0 Pcdh17 0.2
Gjb1 0.0 Actg1 0.2
Gjc3 0.0 Cdh4 0.0
Data are average FPKM (fragments per kilobase of exon per million fragments
mapped) from three independent pooled samples of ventricular zone from
embryonic day 17 (E17) and adult rats. Genes with FPKM expression <1.0 were
considered not expressed (underlined in Table).
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Table 4 | Gene expression of junction related genes in embryonic
ventricular zone and adult ventricular ependyma.
Gene ID Fold change(E17/Adult) Fold change(Adult/E17)
ACTINS
Actb 6.96 0.14
Actg1 Present in embryo only
Actl6b Present in embryo only
Actn4 No difference between ages
Actr10 2.32 0.43
Actr1a 3.79 0.26
Actr1b 0.32 3.17
Actr2 2.36 0.42
Actr3 3.94 0.25
Actr3b Present in adult only
CADHERINS
Cdh13 Present in embryo only
Cdh2 12.53 0.08
CLAUDINS
Cldn11 Present in adult only
Cldn5 Present in embryo only
CATENINS
Ctnna1 No difference between ages
Ctnna2 3.54 0.28
Ctnnb1 3.95 0.25
Ctnnbip1 Present in embryo only
Ctnnbl1 Present in embryo only
Ctnnd2 No difference between ages
GAP JUNCTION PROTEINS
Gja1 Present in adult only
Gjb1 Present in adult only
Gjc3 Present in adult only
JUNCTIONAL ADHESION MOLECULES
Jam2 Present in adult only
Jam3 Present in adult only
PROTOCADHERIN
Pcdhgc3 3.49 0.29
PLAKOPHILIN
Pkp4 Present in adult only
Average fold change in FPKM (fragments per kilobase of exon per million frag-
ments mapped) from three independent pooled samples of ventricular zone
from embryonic day 17 (E17) and ependyma from adult rats.
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under
accession code GSE44072.
Statistical analysis
Where applicable, data are expressed as mean ± SEM, or as a
single mean value (RNA sequencing data). Where no SEM is
provided the data are either a single value or a mean of two.
RESULTS
This study aimed to characterize the permeability properties of
the CSF–brain interface during mouse development and to cor-
relate it with changes in the expression of identified junctional
proteins and cellular distribution of their protein products.
FIGURE 2 | Distribution of Biotin Ethylene Diamine (BED). Coronal
sections (paraffin embedded) through cortical wall surrounding lateral
ventricles of E17, E19, and P0 mouse brain after BED injection into the
contralateral ventricle. Developed with DAB reaction. Note that at E17 there
is cellular uptake of BED in some regions of the ventricular zone, but none
appears to have penetrated into the brain extracellular space. At E19 and P0
there is both cellular uptake and diffusion into the extracellular space of the
brain, especially into the ventral side of the ventricle. Much less staining is
detected in the medial wall at all three ages. VZ, ventricular zone; CP,
choroid plexus. Scale bar 100μm in left panels and 50μm in right panels.
PERMEABILITY PROPERTIES OF THE CSF-BRAIN BARRIER IN
DEVELOPMENT
The permeability characteristics of the CSF–brain barrier were
investigated using three different sized biotinylated dextran
amines conjugated with rhodamine: 3, 10, and 70 kDa. In addi-
tion a small marker of 268Da (BED) was used in fetal animals at
E17, E19, and in P0. All animals, from E17 to adult, received an
injection of 25mg ml−1 of marker in sterile saline into one lateral
ventricle as described in the Materials and Methods. Vibratome
and paraffin-embedded microtome-cut sections from the ventri-
cle contralateral to the injected side were analyzed. Results are
illustrated in Figures 2, 3 and summarized in Figure 4.
268DA BIOTIN ETHYLENEDIAMINE (BED)
Following injections into the lateral ventricle of E17 mice, BED
was detected in many cells lining the ventricular system but not
in at all aspects of the ventricular lining. BED reaction product
was also faintly visible in the extracellular space of the ventricular
zone between the cells (Figure 2). By E19 and P0, cellular uptake
of BED was visible at all aspects of the ventricular lining and the
extracellular staining in the brain parenchyma was clearly positive
(illustrated in Figure 3). The results from fetal animals indicated
that at these ages there is limited diffusion of molecules as small
as 286 Da BED, between radial glial cells lining the CSF-brain
interface. Uptake by individual ventricular cells was also present
(Figure 2).
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FIGURE 3 | Diffusion of different sized rhodamine labeled biotinylated
dextrans (BDA) into postnatal mouse brain. Vibratome coronal sections
(80μm thick) through cortex of mice injected with different sized BDAs (3, 10,
and 70 kDa). Markers were injected into the contralateral ventricle and left to
diffuse for 2–3min at E19 and P0, 5min at P10 and 10min in the adult. Note that
none of the dextrans entered the brain at E19. In older brains there was a
progressive increase in penetration depending on the size of the dextran. By
adulthoodall threedextranswereentering thebrain to a similar extent. Apparent
diffusion distances shown in Figure 4. Distribution of BED (286Da) is illustrated
inFigure 2 for comparison.E, embryonicday;P, postnatal day.Scalebar 500μm.
3 KDA RHODAMINE BDA (BDA3 KDA)
Following injections of BDA3 kDa into fetal (E17 and E19) lat-
eral ventricles BDA3 kDa was detected in some cells lining the
ventricular zone (Figure 3) but was not detected in the extracel-
lular space of the brain, indicating that at these ages the diffusion
of molecules of at least 3 kDa across the CSF-brain barrier was
limited. It is possible that the specialized cellular uptake of small
molecules may be the primary mechanism allowing their access
to the early developing brain.
The earliest age at which diffuse labeling in the extracellu-
lar space of the brain was detected was in newborn pups (P0).
At that age more BDA3 kDa appeared to diffuse into the medial
aspect of the ventricle (as shown by a greater intensity of fluores-
cent marker, Figure 3) and indicates that the permeability of the
inner CSF–brain barrier allows unhindered diffusion of a 3 kDa
molecule from about the time of birth in mice (Figures 3, 4).
10 kDa RHODAMINE BDA (BDA10 kDa)
Diffusion of BDA10 kDa into the brain around the whole ven-
tricular zone interface was prevented in E17 and E19 mice, as
no fluorescent labeling was visible at either age in the brain (see
Figure 3). At P0 results for BDA10 kDa were variable—a small
amount of the marker (not measurable) was detected diffusing
into the extracellular space of the ventricular zone in one pup
from one litter, while in 2 other pups no diffusion was observed.
This may indicate that at this stage of development there is a
change in the permeability properties of the CSF–brain interface
and a small difference (hours) in the age of the pups could explain
the observed results. At older ages (P10 to adult) BDA10 kDa
was found in brains from all animals including some intercel-
lular presence in the ependymal layer. Thus, the permeability of
the CSF–brain barrier changes between P0 and P10 to allow the
diffusion of molecules up to 10 kDa (Figures 3, 4).
70 kDa RHODAMINE BDA (BDA70 kDa)
The earliest age at which BDA70 kDa was observed to diffuse into
the brain was in P10 animals (Figure 3); however, this was only
detected in the medial and lateral aspects of the ventricle. At P20
results were variable. In one litter, where two pups received an
injection of 70 kDa, diffusion into the ventricular zone was appar-
ent in one brain but not in the other. In pups from a second
litter (n = 2), diffusion was not observed in the brain of either
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FIGURE 4 | (A) Apparent diffusion distance for three different sized
biotinylated dextrans. The values were obtained by measuring the distance
to which each marker penetrated into the dorso-lateral wall of the lateral
ventricle after injections were made in the contralateral side. Mean ± SEM
(only if n > 2), values from individual experiments are illustrated as circles
in (B–D). P, postnatal day. Note that none of the dextrans penetrated at E19
(see B–D and Figure 3). (B,C) Standardized apparent diffusion distances
compared to theoretical values. Apparent diffusion distances were
standardized by estimating the apparent diffusion distance at 1min after
intraventricular injection of each dextran at each age using Fick’s second
law of diffusion as different sized dextrans were left to diffuse for different
periods of time (see Materials and Methods). The broken lines represent
the calculated theoretical diffusion distance at 1min. Each circle represents
(Continued)
FIGURE 4 | Continued
a value obtained from individual pups. (B) BDA3kDa appeared to diffuse
without restraint from P0. There was no diffusion at E17 or E19 (only E19
illustrated). (C) BDA10 kDa did not enter the ventricular zone at P0 and
appeared to diffuse less than the theoretical distance at P10 and P20. (D)
BDA70 kDa only penetrated the ependyma at P20 in one pup out or four
and in the adult. E, embryonic; P, postnatal.
animal. In the adult brain (n = 2) diffusion of the probe was
observed from the ventricle into the brain in both animals. These
results indicate that after the age of weaning (>P20) in the mouse
there is no longer any size related diffusion restraint present at the
CSF-brain interface for molecules up to 70 kDa (Figures 3, 4).
TOTAL PROTEIN CONCENTRATION IN CSF AND PLASMA OF MICE
FROM E15 UNTIL ADULT
In order to establish if there is a correlation between changes in
the permeability properties of the inner CSF–brain barrier and
protein concentration in the CSF during brain development, total
protein concentration in plasma and CSF of mice from E17 to
adult was measured using the Bradford method (Bradford, 1976
see Materials and Methods). Results are shown in Figure 5. For
completeness values obtained from a previous study (Liddelow
et al., 2012) from E15 mice are also included.
As can be seen from Figure 5A the concentration of total
protein in the CSF was higher in younger than in adult ani-
mals. There was no statistically significant difference between late
fetal (E17 and E19) and P0 protein concentrations in CSF with
values ranging from 227 ± 1.7mg 100ml−1 at E17 to 259 ±
23.7mg 100ml−1 at P0. However, there was a statistically signif-
icant difference between protein concentrations in the CSF at P0
(259 ± 23.7mg 100ml−1) and P2 (201 ± 6.9; p = 0.02). After P2
there was a decline until adult levels were reached (26 ± 1.5mg
100ml−1). In contrast, total protein concentration in plasma
was lowest at E15 (465 ± 32.4mg 100ml−1) and increased to
6188 ± 51.5mg 100ml−1 in adult plasma (Figure 5B). When
these results are compared with the results obtained from perme-
ability studies, it appears that the CSF–brain interface becomes
less size-restricted for molecular diffusion at the time when the
CSF protein levels begin to decline (i.e., after P0).
RNA SEQUENCING ANALYSIS OF EMBRYONIC VENTRICULAR ZONE
AND ADULT EPENDYMA
In order to understand the molecular structure of strap junctions
present between adjacent neuroepithelial ventricular zone cells in
mouse fetal brain we employed RNA Sequencing analysis of lat-
eral ventricular zone tissue from E17/18 embryos and ependyma
from adult mice. Only the dorsolateral part of the lateral ven-
tricular wall was sampled (see Materials and Methods). In this
paper we focus only on genes that are thought to play a role in
intercellular junctional structures. However, a more comprehen-
sive analysis of the full RNA-Seq dataset dealing with the general
development of the ventricular zone will be published elsewhere.
Table 3 lists the junction-related genes that were identified in
embryonic ventricular zone (A) and adult ependyma (B). The
Table also lists numerous genes known to be associated with tight
junctions that were below the detection threshold of the method.
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In the embryonic ventricular zone only 19 junction-related genes
were present with FPKM (fragments per kilobase of exon per mil-
lion fragments mapped) values above the cut off of 1.0. In the
adult ependyma there were 23 detectable junction-related genes.
In the embryonic ventricular zone 9 genes belonging to the actins
were represented, 6 belonged to catenin gene family, 3 were cad-
herins and one was a claudin (Cldn5). No detectable levels of
genes coding for gap junction proteins were observed. In the adult
ependyma three genes for gap junction proteins were detected,
eight genes were from the actin family, four were catenins and
there was only one cadherin. Claudin-11 (Cldn11) was the gene
expressed at the highest level in the adult ependyma (Table 3).
Genes from this first pass analysis were subsequently grouped by
their molecular categories and represented as differentially reg-
ulated between the two ages (i.e., the fold differences between
E17 and adult). These are summarized in Table 4. In addition,
genes that did not show age-related expression differences are also
listed. Some genes were only present in the embryo in detectable
copy numbers whereas others were present only in the adult.
The largest single category was actin and actin-related genes—
two (Actg1, Actl6b) were present only in the embryo; one (Actr3b)
FIGURE 5 | Total protein concentration in (A) and in CSF (B) during
development in the mouse. Mean ± SEM (n = 3–4). ∗p < 0.05 compared
with previous age group. E15 data from Liddelow et al. (2014). In CSF,
maximum concentration was in the youngest embryos examined (E15). The
lowest concentration was in adults. In plasma the lowest protein
concentration was at E15 with a progressive increase to adulthood.
∗∗∗p < 0.001. E, embryonic day; P, postnatal day.
was present only in the adult. Another five were expressed at a
higher level in the embryo than in the adult (Actb, Actr3, Actr1a,
Actr2, Actr10) in the range 2.3–7.0-fold enrichment. In adult
ependyma only one actin-related gene (Actr1b) was expressed at a
higher level than in the embryo. The cadherin, Cdh13 was only
present in the embryo, while Cdh2 was expressed at both ages
but 13-fold higher in embryos than in the adult. Two claudins
were detected, Cldn5 only in the embryo and Cldn11 only in the
adult. Four catenins showed age-related differences in expression,
all at a higher level in embryos. Two were present only in the
embryo (Ctnnbip1,Ctnnbl1) and 2 were expressed at a higher level
in the embryo (Ctnna2, 3.5-fold and Ctnnb1, 3.9-fold); the one
protocadherin detected (Pcdhgc3) was also expressed only in the
embryo. The gap junction (Gja1,Gjb1,Gjc3), junctional adhesion
molecules (Jam3, Jam3) and one plakophilin (Pkp4) were all only
expressed in the adult ependyma.
A summary of genes that were only present in embryonic ven-
tricular zone or adult ependyma is listed in Table 5, together with
genes that were expressed at similar levels at both ages.
DISTRIBUTION OF JUNCTIONAL PROTEINS AT THE INNER CSF-BRAIN
INTERFACE
The overall distribution and cellular localization of the adherens
junctional proteins N-cadherin (product of gene Cdh2), α- and
β-catenin (Ctnna1 and Ctnnb1) and of the tight junctional pro-
teins claudin-5 and -11, (Cldn5 and Cldn11), were investigated
Table 5 | Junction-associated genes present only at E17 or adult or
not different at these ages in mouse ventricular zone/ependyma.
Gene ID E17(AVE FPKM) Adult(AVE FPKM)
PRESENT AT E17 ONLY
Actl6b 7.7 0.9
Actg1 2.0 0.2
Ctnnbip1 1.6 0.3
Ctnnbl1 1.3 0.2
Cdh13 1.2 0.5
Cldn5 1.0 0.3
PRESENT IN ADULT ONLY
Cldn11 0.0 304.7
Gja1 0.3 35.9
Pkp4 0.6 31.2
Gjc3 0.0 5.5
Jam3 0.2 3.5
Gjb1 0.0 1.9
Actr3b 0.7 1.1
NO CHANGE IN EXPRESSION
Ctnnd 3.8 2.0
Actn4 1.3 2.2
Ctnna1 1.4 2.6
Data are FPKM (fragments per kilobase of exon per million fragments mapped)
from three independent pooled samples of ventricular zone/ependyma from
embryonic day 17 (E17) and adult mice. Full gene lists were truncated to remove
transcripts with FPKM < 1.00. A fold change was considered significant if it was
greater than 2.00.
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using immunohistochemistry in paraffin embedded sections of
mouse brains from E15/16 to adult. These protein candidates
were chosen based on the transcriptomic analysis of the dataset
as described above (see Tables 3–5). N-cadherin (Cdh2) and
both catenin genes (Ctnna1 and Ctnnb1) were expressed at lev-
els that were higher in the fetal brains. Cldn5 was only detected
in the fetal ventricular zone while Cldn11 was only detected in
the adult. Although transcriptomic analysis was performed on
samples dissected out from only the lateral wall of the lateral
ventricles and most of the permeability data were also calculated
from this area, results from immunohistochemical staining are
described for all areas lining the ventricles and are illustrated in
Figures 6–8.
Overall distribution
Immunostaining at E15/16 for junctional proteins identified
in the transciptomic analysis as those expressed differentially
between fetal and adult ages showed a weak surface staining for
claudin-5 (between the two arrows in Figure 6A) in contrast
to a much stronger reactivity for α-catenin, N-cadherin and β–
catenin, which lined the entire lateral ventricular zone surface
including the ganglionic eminence (Figures 6B,C). N–cadherin
immunoreactivity was similar to that of α-catenin and β–catenin
although it appeared stronger and also clearly included the sur-
face of the ganglionic eminence (Figure 6C). All three adherens
junctional proteins showed increased staining of the borders of
the ganglionic eminence, at the bottom of the septal fork of the
lateral ventricle and the pallio-subpallial boundary (arrows in
Figure 6C).
Cellular distribution
A comparison of immunostaining for junctional proteins of
E15/16 and P20/adult lateral telencephalic wall at high magni-
fication (Figure 7 from boxed areas in Figures 6A–D) showed a
prominent claudin-5 reactivity in endothelial cells of the sinusoid
blood vessels in the subventricular zone but also a distinct stain-
ing corresponding to the apical-most radial glial cell membranes
(Figure 7A). In contrast the ventricular-facing surface of the
ependymal cell lining in lateral ventricle of adult brain was devoid
of claudin-5 reactivity (Figure 7A1), whereas the endothelial cells
of fenestrated blood vessels of the choroid plexus were positive.
Immunostaining for α-catenin, N-cadherin and β-catenin out-
lined the apical and apico-lateral most part of the ventricular
zone cells in the lateral ventricular zone (Figures 7B–D). N-
cadherin and β-catenin immunoreactivity included the cytoplasm
of the radial glial cells (Figures 7C,D arrowheads). In the adult
immunoreactivity for α-catenin was not observed in telencephalic
wall, ependymal cells nor in choroid plexus (Figure 7B1). The
apical ependymal surface was strongly stained for N-cadherin
(Figure 7C1) but virtually no reactivity was found for β-catenin
in the P20/adult forebrain in either the ependyma or in the
subependymal zone (Figure 7D1).
Since Cldn11 was only detected in the adult mouse telen-
cephalic wall we compared immunostaining for claudin-11/OSP
of E16 and P15 mouse forebrain (Figures 8A,B). The early
developing forebrain showed a lack of reactivity in the entire
telencephalic wall. Thus, the apical surface of ventricular
FIGURE 6 | Tight and adherens junctional proteins in embryonic mouse
brain. An overall view of tight and adherens junctional proteins in the
ventricular zone of early mouse CSF-brain interface at low magnification in
coronal sections of E16 brain showing immunostaining for claudin-5 (A),
α-catenin (B), N-cadherin (C), and β–catenin (D). Note the differences in
distribution of immunopositive staining between different regions of the
surface of the ventricular zone with strongest staining of the dorsolateral
telencephalic wall (DLTW) and a weak or lacking immunoreactivity of the
ganglionic eminence (GE). Arrows in A point to the border of faint claudin-5
reactivity of the ventricular surface of the dorsolateral wall, and in (C) to the
increased staining of the dorsolateral and ventral borders of the ganglionic
eminence. The boxed areas in (A–D) are shown in higher magnification in
Figure 7. HIP, hippocampus; LV, lateral ventricle; SF, septal fork of the lateral
ventricle; SVZ, septal ventricular zone. (A–D) Samemagnification, scale bar
500μm.
zone (VZ) facing the lateral ventricle (LV) was completely
devoid of claudin-11 immunoreactivity. The developing
arachnoid barrier layer (arrowheads) was clearly claudin-
11-positive. Leptomeningeal cells in the subarachnoidal
space and on the outer surface of the telencephalic wall
were not stained (Figure 8A). At P15 the ependymal and
the subependymal zone of the lateral ventricle (LV) was
unstained in marked contrast to the strongly stained myeli-
nated early subependymal oligodendrocytes (Figure 8B,
arrows).
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FIGURE 7 | Cellular distribution of adherens and tight junctional
proteins at the lateral CSF-brain interface. High magnification coronal
sections of E16 (A–D) from boxed areas in Figure 6 and of adult (A1–C1)
and P20 (D1) forebrain immunostained for claudin-5 (A,A1), α-catenin
(B,B1), N-cadherin (C,C1), and for β–catenin (D,D1). (A) At E16 claudin-5
reactivity is prominent in endothelial cells of blood vessels (BV), but a
distinct staining is also present corresponding to the apical-most part of the
ventricular zone cells (VZ). (A1) In the adult forebrain ependymal cells (E)
show no claudin-5 immunoreactivity in marked contrast to the positively
stained endothelial cells of fenestrated blood vessels of the choroid plexus
(CP). (B–D) At E16 immunostaining for α-catenin (B), N-cadherin (C) and
β-catenin (D) outlines the apical and apico-lateral most part of the
ventricular zone cells,—compare (A) (apical) and (D) (apical and apico-lateral
staining). N-cadherin and β-catenin immunostaining extends into the
cytoplasm of the ventricular zone cells (arrowheads in C,D). (B1)
Immunoreactivity for α-catenin is not present in adult forebrain, neither in
ependymal cells (E) nor in the choroid plexus (CHP). (C1,D1) The surface of
the ependymal cells (E) is strongly stained for N-cadherin but only little
reactivity is observed after staining for β-catenin in the adult forebrain and
virtually no reactivity is observed in the subependymal zone. Same
magnification in (A–D) and (A1–D1). Scale bar 50μm.
DISCUSSION
The brain develops within a well-defined environment that is
controlled by a set of mechanisms present at the blood–brain bar-
riers, which determine the exchange of molecules between the
brain and the periphery (Saunders et al., 2012). The molecular
exchange between the brain interstitial fluid, peripheral circula-
tion and the CSF occurs across the interfaces between the brain,
the blood and the CSF (Saunders et al., 2012). Properties of two
of these barriers, the blood–brain barrier proper (between the
brain and the blood) and the blood–CSF barrier (between the
blood and the CSF) have been extensively studied, including dur-
ing development (for review see Saunders et al., 2012) but the
inner CSF–brain barrier, the last frontier together with the outer
FIGURE 8 | Distribution of claudin-11/OSP immunoreactivity in coronal
sections of E16 (A) and P15 (B) mouse forebrain. (A) Immunostaining for
claudin-11/OSP of the early developing forebrain at E16 demonstrates a lack
of reactivity in the entire telencephalic wall. Thus, the apical surface of
ventricular zone (VZ) facing the lateral ventricle (LV) is devoid of
immunostaining in all subregions— DLTW, dorsolateral telencephalic wall;
MW, medial wall; SVZ, septal ventricular zone and GE, ganglionic
eminence. The developing arachnoid barrier layer (arrowheads) is however,
claudin-11/OSP positive. Leptomeningeal cells in the subarachnoidal space
(SAS) and on the outer surface of the telencephalic wall are not stained.
(B). At P15 the ependymal zone (E) of lateral ventricle (LV) is unstained in
marked contrast to the strongly stained tight junctions of myelin sheaths in
early subependymal oligodendrocytes (arrows). Same magnification in
(A,B), scale bar 200μm.
CSF-brain barrier as it were (see Brøchner et al., in preparation),
is not well understood.
PERMEABILITY OF THE INNER CSF-BRAIN BARRIER
Here we have presented a study to investigate systematically the
permeability properties of this inner barrier during development.
Only one study has previously attempted to do so and also found
that there was a size restriction at earlier ages compared to free
diffusion at later stages of brain maturation (Fossan et al., 1985).
However, in the study of Fossan et al. (1985) only one sized
marker (HRP, 40 kDa) was used and only two developmental
stages in fetal sheep were compared. The only other studies of
ventricular zone in embryos appear to be those of Chang and
Sive (2012a,b) in zebrafish. As in the present report, these authors
used a series of different molecular sized dextrans (10–400 kDa
FITC-conjugated) injected into the cerebral ventricles of zebrafish
embryos as early as 22 h post fertilization. In 24 h post fertilization
embryos the smallest 10 kDa dextran “leaked almost immediately
into the neuroepithelium, whereas the 70 kDa dextrans moved
only slowly into that tissue and 2000 kDa not at all.” This con-
trasts with our results in mouse embryos (Figures 2, 3) in which
even the smallest marker barely penetrated between the cells of
the ventricular zone at E17-E19. This difference in permeability
of the ventricular zone in the two studies could be due to the
difference in species or to the stages of development examined.
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Results presented here demonstrate that at early stages of fetal
mouse brain development the CSF–brain interchange of inert
lipid insoluble molecules is restricted for ones as small as 286 Da
BED (Figure 2). The 3 kDa probe was not detected in the brain
extracellular spaces until P0 (Figure 3). The size restriction for
free diffusion appeared to progressively relax and after P20, the
CSF–brain barrier no longer hindered diffusion of protein–sized
molecules such as BDA70 kDa (Figure 3). However, both BED
and BDA3 kDa were detected intracellular in the brain ventricu-
lar zone in some cells lining the lateral ventricles (Figure 2). This
indicates that the primary mechanism involved in the potential
penetration of lipid insoluble molecules, including larger com-
pounds such as proteins (Cavanagh and Warren, 1985), into the
early developing brain is restricted to specific cellular uptake and
does not occur by non-specific intercellular diffusion.
In the present study the distance to which each sized probe dif-
fused at each stage of brain development was estimated. However,
in such an approach, penetration of a probe in vivo does not occur
in an entirely free, unrestricted diffusion pattern. Values calcu-
lated in the present study were mostly less than the calculated
theoretical rate using Fick’s second law (a mathematical repre-
sentation of free diffusion) even after allowing longer times for
larger molecules to diffuse into the brain. The difference is most
likely to be due to (i) CSF flow, (ii) the ventricular surface bar-
rier, (iii) the cellular architecture of the brain into which the
probes diffuse, and (iv) bulk flow of the interstitial fluid of the
brain. Nevertheless, the results obtained from such calculations
indicated that by adulthood the passive diffusion of molecules
as large as 70 kDa was unrestricted while earlier in development
the size restriction was progressively relaxed as the brain matured
(Figure 4).
There is little information available about the rate of CSF flow
in immature brains (Saunders, 1992) but the flow of brain inter-
stitial fluid was studied previously by Cserr and her colleagues
(e.g., Cserr et al., 1981; Szentistványi et al., 1984; Cserr, 1988).
Their findings have been followed up recently using 2-photon
microscopy (Iliff and Nedergaard, 2013; Thrane et al., 2013). The
brain does not appear to possess a true lymphatic system like the
rest of the body, although drainage from brain interstitial fluid
into the cervical lymphatics has been demonstrated by studies
over more than the past 100 years (see Abbott, 2004). Iliff and
Nedergaard (2013) have coined the term, the glymphatic system
to describe this drainage of the bulk flow of solutes. Fluid first
flows via the para–arterial space—or Virchow–Robin space—and
diffuses into the interstitial fluid. The interstitial fluid and solutes
then diffuse into the brain parenchyma facilitated by astrocytes
that possess aquaporin–4 (AQP–4) which assist in water trans-
port. AQP–4 is expressed on the endfeet of astrocytes that line
the para–arterial and para–venous spaces. Interstitial fluid and
solutes are then drained via the para–venous spaces, which sur-
round major drainage veins (Iliff and Nedergaard, 2013; Thrane
et al., 2013; Xie et al., 2013).
In this study BDA probes of all three sizes were visible in the
brain within many blood vessels but on closer inspection under
the microscope it became apparent that these molecules were
confined to the para–vascular (Virchow–Robin) spaces. This is
illustrated in Figure 9 where an example of large vessels in the
FIGURE 9 | Paravascular distribution of biotin dextrans, following
intraventricular injection. Coronal sections of adult brains following
intraventricular injection of BDA70K (A) or BDA10K (B). Note that most of
the tracer is present in the paravascular or Virchow-Robin space and not in
the lumen of blood vessels. Scale bar 200μm.
adult brain after an intraventricular injection of BDA70 kDa or
BDA10 kDa is shown.
The importance of our findings lies primarily in the obser-
vation of the impermeability of the CSF-brain interface early in
development and its gradual opening up to progressively larger
molecules in the postnatal period in the mouse. These perme-
ability changes and those describer earlier in fetal sheep (Fossan
et al., 1985) correlate with the presence of strap junctions in the
ventricular zone of the developing brain and their subsequent
disappearance at later stages of development (Møllgård et al.,
1987).
CSF AND PLASMA PROTEIN CONCENTRATION
Part of the hypothesis of this study was that changes in the per-
meability of the CSF–brain barrier could be related to changes
in protein concentration in the CSF (see Introduction). Results
showed that the CSF protein concentration in the mouse embryo
was highest at E15 followed by E17 and E19. There was a
decline in protein concentration from P0 to P20. This drop in
CSF protein concentration between P0 and P10 seems to coin-
cide with the appearance of unhindered diffusion of BDA3 kDa
and BDA10 kDa into the brain. The unrestricted diffusion of
BDA70 kDa coincides with the drop in protein concentration
between P10 and P20. By adulthood all three probes were visible
in the brain extracellular space lining the ventricular system and
the CSF protein concentration was at a minimum (Figure 5B).
Previous studies have shown that the premature infiltration of
protein into the brain during development is closely linked with
altered neurogenesis (Stolp et al., 2011b). Neurogenesis begins in
the mouse ventricular zone at approximately E13.5 and astroglio-
genesis begins to occur in the brain between the approximate ages
of E16 and E18 (Götz and Huttner, 2005; Stolp et al., 2011a,b).
This is around the age when the CSF protein concentration began
to drop, the permeability properties of the barrier were trans-
forming, and when progressive remodeling of the barrier with
respect to junctional proteins was beginning to occur (see below).
MOLECULAR MAKE-UP OF STRAP JUNCTIONS
Strap junctions between cells lining the ventricular zone have only
been described in embryonic brains (Møllgård et al., 1987). Their
molecular structure is not known but freeze fracture images show
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cell-cell junctional interactions that are thought to exclude inter-
cellular passage of molecules between CSF and the brain (Fossan
et al., 1985; Møllgård et al., 1987). Permeability studies described
in the present study identified changes in the size of molecules
able to diffuse across this interface. This is the first study in which
an attempt was made to describe possible molecular make up of
strap junctional complexes.
Because the molecular structure of strap junctions is not
known it seems reasonable to suggest that genes that are expressed
exclusively in the embryonic ventricular zone, or at least at a
higher level than in the adult, will be involved in their formation.
By the same token it would seem unlikely that genes expressed
only or at a higher level in the adult would be involved in strap
junction structure. However, the genes that are expressed at both
ages, but not differentially so, could not be ruled out as contribut-
ing to strap junction structure. In fact only three such genes were
identified (Actn4, Ctnna1, and Ctnnd2, Table 5).
A striking finding was that very few of the genes known to be
involved in intercellular tight junction formation (see Bauer et al.,
2011; Van Itallie and Anderson, 2014) appear to be expressed
in the ventricular zone of the lateral wall of the lateral ventricle
in mouse embryos. Claudin-5 has been associated with cerebral
endothelial tight junctions (Nitta et al., 2003). In this study its
gene was only detected in the embryo, albeit at a rather low level
(FPKM—1.00, the lowest level of detection using this method).
Our immunohistochemical results showed prominent staining
for claudin-5 in endothelial cells of blood vessels in the sub-
ventricular zone at this age; but there was also some distinctive
immunostaining of the apical-most part of the ventricular zone
cells (Figures 6, 7). Claudin-5 has also been demonstrated in
the ventricular zone of zebrafish embryos (Zhang et al., 2010).
These authors and others (e.g., Chang and Sive, 2012a) have inter-
preted this as indicating that the ventricular zone/neuroepithelial
cells are joined by tight junctions. The transmission electron
micrographs in Zhang et al. (2010) are too low resolution for
identification of the nature of the intercellular junctions, but loss
of claudin-5 resulted in disruption of these intercellular junc-
tions and allowed passage of lanthanum. As shown by Møllgård
et al. (1987) it requires freeze fracture to identify these junc-
tions as strap junctions. Otherwise in our data set transcripts
for traditionally important tight junction protein genes such
as occludin, MAGUK-like proteins, including ZOs, tricellulin
(MarvelD2), JAMs, ESAM, were not detectable. This is in spite
of their presence, as detected by immunohistochemistry, as early
as E12 mouse (Møllgård et al., unpublished observations) and
immunostaining for ZO-1 in zebrafish embryonic neuroepithe-
lium (Zhang et al., 2010). The expression of Cldn5 (Table 4)
and its presence demonstrated by immunohistochemistry (see
Figure 7A) together with lack of expression of many other tight
junction genes suggests strongly that claudin-5 may be a com-
ponent of strap junctions in the embryonic ventricular zone.
In addition, representatives of all three of the key gene families
involved in cell adhesion in epithelia (Adams et al., 1996) were
present and expressed either exclusively or at a higher level in
the embryo (Table 4). These were seven actin or actin-related
genes, two cadherins, one protocadherin and four catenins. It has
been thought for a long time (Adams et al., 1996) that the actin
cytoskeleton stabilizes epithelial intercellular junctions by attach-
ment to cadherins (Hirano et al., 1987; Matsuzaki et al., 1990) via
cytoplasmic interactions with catenins (Nagafuchi and Takeichi,
1988; Ozawa and Kemler, 1992). However, more recently this con-
cept has been challenged and it appears that the linkage between
the cadherin-catenin complex and actin filaments may be more
dynamic than previously thought (Drees et al., 2005; Yamada
et al., 2005; Weis and Nelson, 2006). Zhang et al. (2010) illustrate
quite widespread immunostaining for actin in 30 h post fertiliza-
tion zebrafish embryos but do notmention which antibodies were
used.
In epithelia of metazoans specialized cell-cell adhesion pro-
teins comprise the classical cadherin/β-catenin/α-catenin com-
plex and it is the cadherins that provide the link between adjacent
cells and catenins that link the cadherins to the underlying actin
cytoskeleton (Miller et al., 2013). Our current RNA-Seq data
shows that all of the key components of intercellular adhesion
junctions are present in the ventricular zone of mouse embryo
lateral ventricles although some of the specific genes are different
from those usually identified in adherens junctions of mam-
malian epithelia. The expression of these adherens junctional
genes in the ventricular zone of the embryonic mouse brain is
consistent with previous ultrastructural studies of the ventricular
zone in the developing sheep and human brain showing the pres-
ence of well-formed adherens junctions between the cells in this
region (Saunders and Møllgård, 1984; Møllgård and Saunders,
1986).
The ultrastructural information available shows that the ven-
tricular zone junctions have a particular configuration of a single
strand in freeze fracture, which has an orientation perpendicu-
lar to the CSF surface of the cells rather than a circumferential
“belt-like” configuration typical of tight and adherens junctions;
although in thin-section electronmicroscopy these junctions have
been described as having tight junction and adhesion-like ele-
ments (Møllgård et al., 1987). The typical intercellular junctions
in the adult ependyma are prominent gap junctions, whereas
only few and small gap junctions associated with the strap junc-
tional elements are present in the embryonic ventricular zone (see
Figure 9A in Møllgård et al., 1987). In marked contrast to this,
strap junctions are only present in the ventricular zone of the
early developing brain (Møllgård et al., 1987). It is noteworthy
that in the current study it was only in the adult that gap junc-
tion genes were identified (Gja1, Gjb1, Gjc3, see Table 4). Also in
adult ependyma only one actin-related gene was expressed at a
higher level (Actr1b); in addition, one claudin (Cldn11), two Jams
(Jam2 and Jam3) and one plakophilin (Pkp4) were expressed at a
higher level. Two catenin genes were present in adult ependyma
but expressed at a much lower level than in the embryo, whereas
another was expressed at the same level at the two ages. Thus, it is
quite clear that the gene profile of junction-related genes is quite
different in embryonic ventricular zone and in adult ependyma.
Actins, particularly β-actin are also important for a variety
of other cellular functions some of which may be related to
their presence in the ventricular zone of embryonic brain. β-
actin has been suggested to comprise between a half to two
thirds of mammalian brain actin (Choo and Bray, 1978; Otey
et al., 1987) although in a β-actin knock out actin levels were
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maintained by upregulation of γ- and α-smooth muscle actin;
however there was about 70% perinatal lethality (Cheever et al.,
2012). β-actin is involved in a range of cellular functions during
development including migration (Ayala et al., 2007) and growth
cone guidance (Dent and Gertler, 2003). These functions may
be important for the differentiation and migration of ventricu-
lar zone cells, which contribute to the formation of the layered
neocortex (Molnár and Clowry, 2012). It does seem therefore that
the main families of proteins involved in strap junction formation
are likely to be actins, cadherins, catenins and claudin-5. Some of
these proteins were also investigated by immunohistochemistry to
establish their cellular distribution (see below).
LIMITATIONS OF THE STUDY
Permeability
A number of factors may have affected the outcomes of the per-
meability experiments. During development the volume of the
lateral ventricles changes and the distance between the ventricles
and from the cerebral surface to the interior of the ventri-
cles increases (Liddelow et al., 2011) as does the flow of CSF
(Saunders, 1992). Thus, the likelihood of a successfully injected
probe reaching the contralateral ventricle can be variable. In order
to overcome these limitations, the volume of dextran that was
injected was increased with age and the time allowed for the dex-
tran to diffuse into the contralateral ventricle was also increased.
These limitations appear to be more significant in the older
ages and this was reflected in the reduced number of successful
injections in P20 and adult animals.
Great care was taken to inject the same volume into each ven-
tricle at each age, but it was difficult to determine how much
of this diffused into the contralateral ventricle. This limited the
ability to properly measure the diffusion distances and then accu-
rately compare them between animals. Intraperitoneal injections
of these probes would at first appear to be the solution to this
problem; however, with age, the amount of probe that needed to
be introduced would have to be increased dramatically to offset
the loss through renal excretion. Obstruction of the renal sys-
tem has been used to restrict such losses thus retaining higher
concentrations of marker in blood, but may represent an un-
physiological state and was deemed unnecessarily stressful for the
animals (Habgood et al., 1993). The most consistent approach to
such experiments is an in vivo ventricular perfusion (as was done
in fetal sheep, Fossan et al., 1985). This is impracticable in mice
due to their very small size, especially at fetal stages.
Animal ages, numbers and injection route
The small size and vulnerability of exposed fetuses meant
that numbers of fetal animals with successful injections ranged
between one and three experimental animals per age, mostly two
separate litters. For each probe all postnatal experiments were
conducted on pups from a minimum of two different litters.
Morphology
For the permeability studies brains were embedded in agar
and cut into 100μm sections using the vibratome (Leica).
This method allowed for clearer observation of the diffusion of
molecules into the brain. Some brains were embedded in paraffin
and cut into 5μm thick coronal sections. This method better
indicated the cellular uptake of the probes.
Cellular distribution of junctional proteins
There is no information available about the molecular compo-
sition of strap junctions limiting the ability to use immuno-
histochemistry to detect cellular changes at this interface.
Immunohistochemistry of candidate proteins was based on the
RNA-Seq results. It is possible that some other junctional pro-
teins, that were either below the detection levels or were sim-
ply not identified in the transcriptomic analysis, could also be
involved. We are preparing a more comprehensive immunohisto-
chemical study of strap junctions using all available antibodies to
junctional proteins (Møllgård et al., unpublished observations).
Sampling of the lateral wall of the lateral ventricles and RNA-Seq
analysis
The lateral wall of both lateral ventricles was carefully dissected
out under a dissecting microscope. However, it is inevitable that
some tissue from the sub-ventricular layer was also obtained. This
probably explains the finding of a high level of cldn11 in adult
mice. Tight junctions of myelin sheaths in developing subependy-
mal oligodendrocytes were strongly positive for claudin-11/OSP
(oligodendrocyte-specific protein, Figure 8B) after P10 and the
developing claudin-11 positive arachnoid barrier layer present in
E16 (see, Figure 8A) was not within the dissected sample. The
dissected samples from E17/18 lateral telencephalic wall would
have included claudin-5 positive blood vessels in the subventricu-
lar zone (Figure 7A), but also in the adult subependymal layer.
Claudin-5, occludin and ZO-1 are known to be present in the
blood vessel tight junctions from their earliest development. In
this studyOccl and Tjp1 (ZO-1) expression were not detected pre-
sumably because they were below the detection level. Small gap
junctions also connect adjacent neuroepithelial cells in the ven-
tricular zone but no gap junctional proteins were detected, i.e.,
were also below the detection level.
We avoided contamination by the choroid plexus and checked
RNA-Seq datasets for choroid plexus specific genes such as
transthyretin (Dickson et al., 1985; Thomas et al., 1988). Samples
used in this study were transthyretin negative. Because of the
unknown degree of possible contamination of the sample by
underlying sub-ventricular zone cells, the datasets were only
mined for known junctional proteins. This, in principle, limited
our analysis to intercellular complexes mostly occurring in the
ventricular zone/ependymal layer. It is possible that there are as
yet unrecognized junctional genes in our data set that contribute
to the structure of strap junctions.
CONCLUSION
We have studied the permeability properties and junctional-
protein characteristics of the inner CSF-brain interface during
mouse brain development. Permeability of this barrier gradually
changed from highly restrictive (to molecules even as small as
286Da size) in fetal ages to unrestricted diffusion (to molecules
at least as large as 70 KDa) in the adult. Molecular characteriza-
tion, using RNA Sequencing of the ventricular zone (fetus) and
ependyma (adult), identified several genes of known junctional
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proteins that are expressed at this inner CSF-brain barrier in a
developmentally regulated manner. It was also found that the age-
dependent changes in permeability characteristics correlate with
changes in the cellular distribution of junctional proteins: cad-
herins, catenins and claudin-5. We suggest that these junctional
proteins are involved in the formation of strap junctions and in
regulation of the changing diffusional properties of this barrier.
Further work will be required to establish the scope of the control
mechanisms in the CSF-brain interface during development and
their significance for normal brain development.
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